MedLife, Romania’s largest private healthcare network and the only Romanian-owned company among the top private healthcare operators listed on the stock exchange, has announced that its Board of Directors has authorized an increase in its syndicated loan by up to €50 million, bringing the total to €330 million.
The banking syndicate signing the credit limit increase includes Banca Comercială Română (BCR) as coordinator, mandated lead arranger, documentation agent, facility and security agent, and lender. Other participating financial institutions include Raiffeisen Bank, BRD Groupe Société Générale, and Banca Transilvania as lead arrangers and lenders, along with ING Bank N.V. Amsterdam Bucharest Branch as a lender.
“Since our listing, MedLife has been an acquisitive company with outstanding results, both in acquiring new businesses and integrating them successfully. As a result, the Group has achieved an average annual revenue growth of over 20% in the last five years, driven by both organic expansion and acquisitions. The year 2024 was focused on consolidation, and despite the slowdown in national economic growth, we have managed to improve our financial and operational performance while reducing debt levels,” said Mihai Marcu, President and CEO of MedLife Group.
“This new syndicated transaction reaffirms our commitment to supporting local leaders investing in sustainable development and international expansion. As lead arranger, BCR has structured a flexible financing package tailored to the needs of a rapidly expanding group. We believe in MedLife’s strategy and are proud to contribute to a project shaping the future of the regional healthcare ecosystem, making a difference both in Romania and beyond,” said Raluca Orha, Head of Loan Syndication at BCR.
“BCR’s role as lead arranger and lender in this credit facility increase and restructuring reflects our trust in MedLife’s vision and our long-term partnership. We believe in the company’s ability to scale a successful business model and its potential to become a regional benchmark in healthcare. This financing provides MedLife Group with the necessary flexibility for its expansion, and we are pleased that BCR is facilitating the development of the healthcare services and infrastructure market,” added Alina Cernat, Head of Consumer and Healthcare Department at BCR.
2024 has been a dynamic year for MedLife, with investments in new robotics, product diversification, and consolidation through organic projects and acquisitions nationwide. The pro-forma consolidated revenue exceeded RON 2.7 billion (€555 million), marking a 25% increase from 2023, making MedLife the first Romanian private healthcare company to surpass half a billion euros in revenue in 2024. Additionally, pro-forma EBITDA reached RON 412 million in 2024, compared to RON 317 million the previous year, demonstrating the Group’s financial stability and growing profitability.
“Taking a prudent approach, the additional funds will primarily be used to finalize ongoing projects and potentially acquire new companies, allowing the Group to sustain its expansion trend while consolidating the healthcare services market and capturing additional profitability. Looking ahead, we will focus more on genetics, nutrition, sports, and preventive healthcare. We strongly believe these fields represent the future of medicine, and we will make significant investments in this direction,” said Mihai Marcu, President and CEO of MedLife Group.